A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
Berkenblit A, Matulonis UA, Kroener JF, Dezube BJ, Lam GN, Cuasay LC, Brünner N, Jones TR, Silverman MH, Gold MA.
Gynecol Oncol. 2005 Oct;99(1):50-7.PMID: 16023182 [PubMed - indexed for MEDLINE]Related articles